AYTU
Aytu BioPharma, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.21
−3.28%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
8.8x
EV/EBITDA
−0.7x
Market Cap
$23.72M
MomentumView details →
1D Return
−3.28%
YTD Return
−15.38%
RSI (14)
43.0
ValuationView details →
P/E (Fwd)
8.8x
EV/EBITDA
−0.7x
Market Cap
$23.72M
RSI (14)
43.0
MomentumView details →
1D Return
−3.28%
YTD Return
−15.38%
SummaryUpdated Mar 1, 2026
Aytu BioPharma, Inc. (NASDAQ:AYTU) is a specialty pharmaceutical company founded in 2015 and headquartered in Englewood, Colorado. Originally incorporated as Aytu BioScience, the company changed its name to Aytu BioPharma in March 2021. The company has undergone significant strategic transformation over recent years, evolving from a multi-segment operation with consumer health and clinical development programs into a focused specialty pharmaceutical company concentrating exclusively on commercializing prescription medications for ADHD and pediatric conditions.
Similar companies
Latest newsMore news →
No recent news for AYTU.